Warning Letter Close-Outs – August 2021
Executive Summary
The US FDA issued three device-related close-out letters in August.
You may also be interested in...
Magellan Lead Test Recall Expanded After First Attempted Fix Found Insufficient
Several additional batches of Magellan’s LeadCare II tests are being recalled as efforts to address the root cause continue.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.